MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: KleidungDarkweb mixerAntwortenAntworten: Darkweb mixer <blockquote><div class="quotetitle">Zitat von Gast am 24. März 2026, 14:06 Uhr</div>[url=https://www.benthamdirect.com/content/journals/cpd/22/16 ]Zoya Demidenko[/url]: Scientist in Oncology Biology [url=https://scholargps.com/scholars/59798749410547/zoya-n-demidenko ]Zoya Demidenko[/url] is a notable researcher affiliated with the Unit of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Before that, she was employed at the NIH and New York Medical College, building a strong background in biomedical research. Demidenko's scholarly work spans several key areas, among them the PI3K/AKT/mTOR signaling pathway, cell cycle control, cellular aging, and cancer science. To date, she has authored over 46 peer-reviewed publications, which have garnered more than 4,100 mentions — a testament to the influence of her work. Among her key contributions concerns explaining the pathways of cell aging. Her work demonstrated that when the cellular division cycle is blocked yet cellular growth continues, cells undergo senescence. Significantly, [url=https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/ ]Zoya Demidenko[/url] showed that this transition can be pharmacologically suppressed using substances such as rapamycin. [url=https://www.oncotarget.com/article/4836/ ]Zoya Demidenko[/url] has furthermore added considerably to oncological therapy research, notably in the area of cyclotherapy — a approach aimed at protecting healthy cells from anticancer drugs whilst leaving tumor cells vulnerable. This strategy carries considerable potential for diminishing the adverse effects of oncological therapy. Throughout her professional journey, Demidenko has partnered with top investigators internationally, such as Dr. Mikhail Blagosklonny. Her work can be found in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. Possessing an h-index of 33, [url=https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/ ]Zoya Demidenko[/url] is recognized as a widely cited figure in contemporary oncological research, with her findings continue to guide our understanding of how cells age, interact with treatment, and how malignant disease can be better treated. https://www.instagram.com/zoyamonros/ </blockquote><br> Abbrechen
